Cargando…
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
SIMPLE SUMMARY: The tryptophan-catabolizing enzyme IDO1 and its metabolite kynurenine were shown to be enhanced in patients with chronic lymphocytic leukemia (CLL), and their involvement in T cell suppression and immune escape was suggested. As we have observed increased IDO1 expression and kynureni...
Autores principales: | Öztürk, Selcen, Kalter, Verena, Roessner, Philipp M., Sunbul, Murat, Seiffert, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071295/ https://www.ncbi.nlm.nih.gov/pubmed/33920868 http://dx.doi.org/10.3390/cancers13081899 |
Ejemplares similares
-
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model
por: Koch, Maximilian, et al.
Publicado: (2020) -
The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
por: Gonder, Susanne, et al.
Publicado: (2021) -
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice
por: Hanna, Bola S., et al.
Publicado: (2020) -
Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
por: Schulze-Edinghausen, Lena, et al.
Publicado: (2019) -
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
por: Roessner, Philipp M., et al.
Publicado: (2020)